Last reviewed · How we verify

NCT07275385: ACE

Advanced Cutaneous Evaluator (ACE): Estimation of Clinical and Economic Impact

Completed NA Last updated 10 December 2025
What this trial tests

NA trial testing Advanced Cutaneous Evaluator (ACE) in Wounds and Injuries in 73 participants. Completed in 6 November 2025.

Timeline
26 March 2025
Primary endpoint
23 October 2025
6 November 2025

Quick facts

Lead sponsorFundacin Biomedica Galicia Sur
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment73
Start date26 March 2025
Primary completion23 October 2025
Estimated completion6 November 2025
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Fundacin Biomedica Galicia Sur — full company profile →

Who can join

Adults 18 to 100, any sex, with Wounds and Injuries or Wound Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

ACE is a clinical decision support system for selecting appropriate products for the local treatment of chronic wounds. It was designed with a user-centered approach, and its usability and feasibility have been previously validated in pilot studies with nurses. This protocol will allow for the clinical validation of the software in 18 primary care centers, including the quantification of the clinical and economic effects of using the tool over 9 months. It is a mixed-methods design that includes a randomized controlled trial in which nursing staff incorporate the use of ACE into their routine clinical practice to support their decision-making process for chronic wound treatment. It also includes a usability evaluation throughout the study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Wounds and Injuries

Currently open trials in the same condition.

Other Fundacin Biomedica Galicia Sur trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07275385.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing